| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Esperite N.V (AS: ESP)
ESP Technical Analysis
5
| As on 28th Oct 2022 ESP STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.03 & Strong Sell for SHORT-TERM with Stoploss of 0.04 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ESPSTOCK Price
| Open | 0.01 | Change | Price | % |
| High | 0.01 | 1 Day | 0.00 | 0.00 |
| Low | 0.01 | 1 Week | 0.00 | 0.00 |
| Close | 0.01 | 1 Month | -0.01 | -50.00 |
| Volume | 1968024 | 1 Year | -0.03 | -75.00 |
| 52 Week High 0.04 | 52 Week Low 0.01 | ||||
AS Netherlands Most Active Stocks
| RDSA | 22.80 | -1.08% |
| PHARM | 0.89 | 2.30% |
| INGA | 14.83 | 0.54% |
| ESP | 0.01 | 0.00% |
| KPN | 3.51 | 0.57% |
| AGN | 5.61 | -0.18% |
| PNL | 1.03 | 0.00% |
| ABN | 14.64 | 0.55% |
| PRX | 38.90 | -0.97% |
| URW | 51.24 | 4.19% |
AS Netherlands Top Gainers Stocks
AS Netherlands Top Losers Stocks
| ESP Daily Charts |
ESP Intraday Charts |
Whats New @ Bazaartrend |
ESP Free Analysis |
|
|
ESP Important Levels Intraday
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
| RESISTANCE | 0.01 |
ESP Forecast December 2024
| 4th UP Forecast | 0.03 |
| 3rd UP Forecast | 0.02 |
| 2nd UP Forecast | 0.02 |
| 1st UP Forecast | 0.02 |
| 1st DOWN Forecast | 0 |
| 2nd DOWN Forecast | 0 |
| 3rd DOWN Forecast | -0 |
| 4th DOWN Forecast | -0.01 |
ESP Weekly Forecast
| 4th UP Forecast | 0.01 |
| 3rd UP Forecast | 0.01 |
| 2nd UP Forecast | 0.01 |
| 1st UP Forecast | 0.01 |
| 1st DOWN Forecast | 0.01 |
| 2nd DOWN Forecast | 0.01 |
| 3rd DOWN Forecast | 0.01 |
| 4th DOWN Forecast | 0.01 |
ESP Forecast2024
| 4th UP Forecast | 0.07 |
| 3rd UP Forecast | 0.05 |
| 2nd UP Forecast | 0.04 |
| 1st UP Forecast | 0.03 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.02 |
| 3rd DOWN Forecast | -0.03 |
| 4th DOWN Forecast | -0.05 |
Esperite N.V ( AS Netherlands Symbol : ESP )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ESP Business Profile
Esperite N.V., together with its subsidiaries, operates as a regenerative and predictive medicine company in the Netherlands, Spain, Italy, Switzerland, and internationally. It operates through four segments: Stem Cell, The Cell Factory, Genoma, and Other. The company collects, processes, and stores human adult stem cells from the umbilical cord blood and the umbilical cord. It also provides proteomics and genomics predictive medicines; and implements its proprietary technology for clinical grade production of autologous mesenchymal and stromal stem cells. In addition, it develops AGAATA, a diagnostic system based on the next generation sequencing technology, as well as allows laboratories to perform their own genetic analysis with the bioinformatics and methods developed by Genoma. The company's products portfolio includes Tranquility, a non-invasive prenatal test; and Cryosave's whole genome sequencing, carrier screening tests, and other products. Further, it engages in biobanking cord blood and cord tissue stem cells business. The company was formerly known as Cryo-Save Group N.V. and changed its name to Esperite N.V. in July 2014. Esperite N.V. was founded in 2000 and is headquartered in Amsterdam, the Netherlands. Address: Herengracht 282, Amsterdam, Netherlands, 1016 BX
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service